Spots Global Cancer Trial Database for thermodox
Every month we try and update this database with for thermodox cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | NCT00617981 | Hepatocellular ... | ThermoDox 5% Dextrose Sol... | 18 Years - | Imunon | |
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | NCT02536183 | Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor... | Magnetic resona... Lyso-thermosens... | - 30 Years | Children's National Research Institute | |
Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) | NCT01464593 | Colon Cancer Li... | Lyso-Thermosens... 5% Dextrose Sol... ThermoDox | 18 Years - | Imunon | |
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) | NCT02112656 | Hepatocellular ... | ThermoDox Dummy infusion | 18 Years - | Imunon | |
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors | NCT02536183 | Pediatric Cance... Solid Tumors Rhabdomyosarcom... Ewing Sarcoma Soft Tissue Sar... Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor... | Magnetic resona... Lyso-thermosens... | - 30 Years | Children's National Research Institute | |
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer | NCT03749850 | Metastatic Brea... Breast Cancer Breast Neoplasm... Stage IV Breast... Metastatic Canc... Invasive Ductal... Invasive Ductal... Adenocarcinoma ... | LTLD MR-HIFU induced... Cyclophosphamid... | 18 Years - | UMC Utrecht | |
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | NCT00617981 | Hepatocellular ... | ThermoDox 5% Dextrose Sol... | 18 Years - | Imunon | |
A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver | NCT00441376 | Hepatocellular ... Liver Neoplasms | ThermoDox | 18 Years - | Imunon | |
Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours | NCT02181075 | Liver Tumour | ThermoDox® (LTL... Focused Ultraso... Pre-LTLD Biopsy... Post-LTLD Biops... Post-LTLD+FUS (... Thermometry of ... | 18 Years - | University of Oxford | |
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer | NCT03749850 | Metastatic Brea... Breast Cancer Breast Neoplasm... Stage IV Breast... Metastatic Canc... Invasive Ductal... Invasive Ductal... Adenocarcinoma ... | LTLD MR-HIFU induced... Cyclophosphamid... | 18 Years - | UMC Utrecht | |
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | NCT00617981 | Hepatocellular ... | ThermoDox 5% Dextrose Sol... | 18 Years - | Imunon |